FRANKLIN, Mass., Feb. 17, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous ...

PHILADELPHIA, Jan. 22, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System as a ...

Echo Therapeutics is developing the Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system. Our target is patients who could benefit from glucose monitoring ...

Data from this study demonstrate that Symphony successfully and continuously monitored glucose levels in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.

FRANKLIN, Mass., Feb. 18 /PRNewswire-FirstCall/ — Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the needle-free Symphony™ tCGM System ...

, a company developing its non-invasive Symphony^® CGM System as a needle-free, wireless continuous glucose monitoring system, today issued a mid-year update to its shareholders outlining the progress ...

You may not have heard of it, but it's kind of like the European "Grammy." It's called the ECHO Klassik Award. Sign up for the Hello, Houston! daily newsletter to get local reports like this delivered ...